RiverVest Venture Partners® focuses exclusively on innovations in life sciences, a field in which our team has significant research, clinical, operational and investment expertise.
Our team’s deep domain experience allows us to identify, promising investment opportunities, particularly in biopharmaceuticals and medical devices. We provide practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward.
RiverVest founds and actively incubates life science companies, including through its Archer Seed Fund. The Firm also invests in select later-stage opportunities to diversify risk and maximize portfolio returns. In every case, we take a hands-on investment approach, preferring to be represented on the boards of our portfolio companies.
• Established in 2000
• $833 million assets under management
• 47 life science companies funded
• 13 companies founded leading to four acquisitions and one IPO
• 22 exits
• 25 commercial medical products currently treating patients
